We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

13 Jun 2019 07:00

RNS Number : 0250C
Sopheon PLC
13 June 2019
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

At today's Annual General Meeting of Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, the Board will give shareholders the following update and review of the business.

 

In recent years, we have described how we have broadened our mission from one that helps R&D organizations to improve innovation, to one that helps major enterprises achieve their strategic goals. This extension of our vision into what some are beginning to call a third major pillar of the enterprise stack - alongside ERP and CRM - has dramatically expanded our horizons and potential. In an increasingly digital world, organizations are challenged to operate with more agility and velocity to survive and thrive; this is where Sopheon can add significant value to our customers. The potential addressable market for this opportunity is substantial. Sopheon continues to benefit from increased market recognition through industry business analysts such as Gartner and Forrester Research, having been named in 22 research reports in 2018.

 

While executing on our growth strategy, we continued to strengthen our financial performance. Once again, revenues, EBITDA and other profit measures in 2018 all exceeded market expectations, and resulted in two upward revisions. Revenues rose 19% to $33.9m from $28.5m in 2017. EBITDA reached $8.9m, up 11% from $8m. Substantial realignment of our debt position in 2017 fed through into an even larger increase in profit before tax, up 25% to $6.4m compared to $5.1m the year before. Our balance sheet ended the year very strong, with net assets rising to $25.6m from $18.6m the year before, and net cash rising to $16.7m from $9.5m; 100% of this growth was generated organically. All of this was accomplished while achieving a historically high recurring revenue retention rate of 97 per cent.

 

We continued to focus on and refine our three core growth strategies − to extend our footprint in existing customers by expanding our enterprise platform, to target new business acquisition with a clear vertical focus, and to develop a partnership ecosystem. These core strategies, along with our tremendous staff and unique culture, have been at the root of our consistent and solid financial performance. The number of larger opportunities in our sales pipeline continues to grow, validating our stated strategy. As always with a mostly perpetual license model, such deals can have a big revenue effect on the period in which they close. In parallel, customer preference for Software as a Service ("SaaS") rather than perpetual licensing in our market is beginning to come through. With our strong balance sheet, we are assessing how to accelerate this migration to an even higher recurring revenue model. We also remain open to M&A opportunities, provided they align with our strategic priorities.

 

When we published our annual report for 2018, we announced a proposal to increase our dividend from 2.5p to 3.25p per share, which we will put to shareholders at today's annual general meeting. We are delighted to be following through on the commitment made last year to maintain a progressive dividend policy, which the Board believes underlines our maturity as a business.

 

Outlook

 

As noted above there are several larger opportunities in our pipeline where we are strongly positioned and that we are confident have a high probability of closing in the coming months. Accordingly, at the time of this AGM full year revenue visibility from contracted business and recurring revenue streams is at similar levels to this time last year, at $23m. We expect this to rise sharply through the summer. In previous years we have typically had a stronger second half and fourth quarter in particular, and we expect 2019 to follow this pattern.

 

It has been very exciting over recent weeks to announce wins in countries like Thailand and Pakistan, representative of the potential for Sopheon of the significant Asian market. We are also seeing traction with partners both in overseas territories and with major management consulting firms. This morning we are delighted to announce the release of Accolade 12.3, with new features specifically designed to help global corporations achieve their digital and business transformation objectives.

 

The Board remains confident of achieving our full year expectations, and in continuing to deliver against Sopheon's strategic goals and expanded vision. The Board looks forward to providing shareholders with a more detailed update at the time of its interim results for the 6 months to 30 June 2019, expected to be released in late August.

 

 

 

 

For further information contact:

 

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (corporate finance)

Alice Lane (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLLFLRRDIFLIA
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.